Evidence map›Paper›PMID 35159946›Full record

ArticleJournal of clinical medicine2022

Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel.

Ana M Calinescu, Omid Madadi-Sanjani, Cara Mack, Richard A Schreiber, Riccardo Superina, Deirdre Kelly, Claus Petersen, Barbara E Wildhaber

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05925309 narecruitingnot on this mapstarted 2023, after this paper: background citation

Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy in Biliary Atresia: a Randomized Controlled Trial

TypeinterventionalSponsorChildren's Hospital of Fudan UniversityRan2023 to 2029Enrolled356ConditionsBiliary Atresia, Cholangitis, Anti-Bacterial AgentsArmsBasic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem, Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
NCT07129655 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: a Feasibility Study

Typeobservational_patient_registrySponsorUniversity Hospital, GenevaRan2025 to 2026Enrolled40ConditionsBiliary Atresia, Kasai Portoenterostomy Status, Cholangitis
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Efficacy and safety of post-Kasai steroid-based protocol in biliary atresia.Journal of pediatric gastroenterology and nutrition · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Biliary atresia.Nature reviews. Disease primers · 2024
    Review
  19. Diseases of bile duct in children.World journal of gastroenterology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Ana M CalinescuDivision of Child's and Adolescent's Surgery, Swiss Pediatric Liver Center, Geneva University Hospitals, University of Geneva, 1205 Geneva, Switzerland.ORCID 0000-0002-3813-8991
Omid Madadi-SanjaniDepartment of Pediatric Surgery, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-7239-8973
Cara MackSection of Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80011, USA.
Richard A SchreiberDivision of Gastroenterology, Hepatology and Nutrition, BC Children's Hospital, University of British Columbia, Vancouver, BC V5Z 4H4, Canada.ORCID 0000-0002-0330-3811
Riccardo SuperinaDivision of Transplant Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Deirdre KellyLiver Unit, Birmingham Women's and Children's Hospital, Birmingham B15 2TG, UK.
Claus PetersenDepartment of Pediatric Surgery, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-1789-7163
Barbara E WildhaberDivision of Child's and Adolescent's Surgery, Swiss Pediatric Liver Center, Geneva University Hospitals, University of Geneva, 1205 Geneva, Switzerland.ORCID 0000-0003-4548-382X
Medizinische Hochschule Hannover · DEUniversity of Geneva · CHBirmingham Women's Hospital · GBChildren's Hospital Colorado · USNorthwestern University · USUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Acute cholangitis during the first year after Kasai hepatoportoenterostomy (HPE) has a negative impact on patient and native liver survival. There are no consistent guidelines for the definition, treatment, and prophylaxis of cholangitis after HPE. The aim of this study was to develop definition, treatment, and prophylaxis guidelines to allow for expeditious management and for standardization in reporting. (2) Methods: the Delphi method, an extensive literature review, iterative rounds of surveys, and expert panel discussions were used to establish definition, treatment, and prophylaxis guidelines for cholangitis in the first year after HPE. (3) Results: Eight elements (pooled into two groups: clinical and laboratory/imaging) were identified to define cholangitis after HPE. The final proposed definitions for suspected and confirmed cholangitis are a combination of one element, respectively, two elements from each group; furthermore, the finding of a positive blood culture was added to the definition of confirmed cholangitis. The durations for prophylaxis and treatment of suspected and confirmed cholangitis were uniformly agreed upon by the experts. (4) Conclusions: for the first time, an international consensus was found for guidelines for definition, treatment, and prophylaxis for cholangitis during the first year after Kasai HPE. Applicability will need further prospective multicentered studies.

Indexed as

biliary atresiacholangitishepatoportoenterostomyKasai

Identifiers

PMID35159946
PMCPMC8836553
OpenAlexW4206793991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.